# Novartis d.o.o. – FDA Inspection, Sep 11, 2020

Source: https://www.keypedia.com/records/fda_inspections/novartis-doo/4bf055c1-d709-40df-8e9a-cbe4a310aab7
Source feed: FDA_Inspections

> FDA inspection 1155320 of Novartis d.o.o., September 11, 2020. Classification: Voluntary Action Indicated (VAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1155320
- Company Name: Novartis d.o.o.
- Inspection Date: 2020-09-11
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1215215 - 2023-07-21](https://www.keypedia.com/records/fda_inspections/novartis-doo/be1f8dbf-ec85-4afd-ab0b-b5d25b8b0ca7)
- FDA Inspection 1228827 - 2022-09-21
- FDA Inspection 1004338 - 2017-02-13
- FDA Inspection 945699 - 2015-09-18
- FDA Inspection 807398 - 2012-10-19

Company: https://www.keypedia.com/companies/novartis-doo/55471e35-a203-4edf-a4b9-fe1ad0bb16fd

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c